Patheon sees faster revenue growth

Article Abstract:

Pharmaceutical company Pantheon Inc of Mississauga, Ontario, has posted a profit of C$4 million, or 12 cents per share, on revenue of C$70.5 million in the FY ended Oct 31, 1998. The company is projecting revenue of more than C$100 million for the current fiscal year as result of its expanded capacity. Pantheon, which is acquiring 300,000-sq-ft pharmaceutical plant in Buffallo, NY, from Bristol-Myers-Squibb Co., operates five plants in Ontario and one in Italy.

Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Drugs, Pantheon Inc.

---

Biovail's 'quarter of note' stronger than expected

Article Abstract:

The details on Biovail Corp., which posted better second quarter financial results, are examined.

Pharmaceutical preparations, Pharmaceutical industry, Company sales and earnings, Company earnings/profit, Biovail Corp.

---

Similar abstracts:

• Abstracts: Canada seen leading G7 growth. Rebound seen across the country. Blackout seen hitting economy
• Abstracts: Aluminum firms trying to rescue merger. Alcan's bigger bid rejected
• Abstracts: First Marathon seeks electronic muscle. Waterhouse profit plunges 90% in quarter
• Abstracts: Geac buying software assets from U.S. firm. Roxio set to relaunch Napster by end of year
• Abstracts: Nestle close to buying Ralston. SEC alleges insider trading in Nestle deal

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.